Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.

Yam C, Mani SA, Moulder SL.

Oncologist. 2017 Sep;22(9):1086-1093. doi: 10.1634/theoncologist.2017-0095. Epub 2017 May 30. Review.

PMID:
28559413
2.

Detecting gene signature activation in breast cancer in an absolute, single-patient manner.

Paquet ER, Lesurf R, Tofigh A, Dumeaux V, Hallett MT.

Breast Cancer Res. 2017 Mar 21;19(1):32. doi: 10.1186/s13058-017-0824-7. Erratum in: Breast Cancer Res. 2017 Apr 13;19(1):48.

3.

Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype.

Johanning GL, Malouf GG, Zheng X, Esteva FJ, Weinstein JN, Wang-Johanning F, Su X.

Sci Rep. 2017 Feb 6;7:41960. doi: 10.1038/srep41960.

4.

Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.

Duhachek-Muggy S, Qi Y, Wise R, Alyahya L, Li H, Hodge J, Zolkiewska A.

Mol Cancer. 2017 Feb 1;16(1):32. doi: 10.1186/s12943-017-0599-6.

5.

TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response.

Isaac R, Goldstein I, Furth N, Zilber N, Streim S, Boura-Halfon S, Elhanany E, Rotter V, Oren M, Zick Y.

Cell Death Differ. 2017 Jan;24(1):132-143. doi: 10.1038/cdd.2016.108. Epub 2016 Oct 14.

PMID:
27740623
6.

MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.

Ho JY, Hsu RJ, Liu JM, Chen SC, Liao GS, Gao HW, Yu CP.

Oncotarget. 2017 Apr 4;8(14):22443-22459. doi: 10.18632/oncotarget.12338.

7.

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers.

Linklater ES, Tovar EA, Essenburg CJ, Turner L, Madaj Z, Winn ME, Melnik MK, Korkaya H, Maroun CR, Christensen JG, Steensma MR, Boerner JL, Graveel CR.

Oncotarget. 2016 Oct 25;7(43):69903-69915. doi: 10.18632/oncotarget.12065.

8.

Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases.

Esparza-López J, Ramos-Elías PA, Castro-Sánchez A, Rocha-Zavaleta L, Escobar-Arriaga E, Zentella-Dehesa A, León-Rodríguez E, Medina-Franco H, Ibarra-Sánchez Mde J.

BMC Cancer. 2016 Sep 20;16(1):740. doi: 10.1186/s12885-016-2769-0.

9.

Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells.

Zhou F, Li M, Wei Y, Lin K, Lu Y, Shen J, Johanning GL, Wang-Johanning F.

Oncotarget. 2016 Dec 20;7(51):84093-84117. doi: 10.18632/oncotarget.11455.

10.

LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.

Sas-Chen A, Aure MR, Leibovich L, Carvalho S, Enuka Y, Körner C, Polycarpou-Schwarz M, Lavi S, Nevo N, Kuznetsov Y, Yuan J, Azuaje F; Oslo Breast Cancer Research Consortium (OSBREAC)SauerTorillGeislerJürgenHofvindSolveigBathenTone FBorgenElinEngebråtenOlavFodstadØysteinGarredØysteinGeitvikGry AarumKåresenRolfNaumeBjørnMælandsmoGunhild MariRussnesHege GSchlichtingEllenSørlieThereseLingjærdeOle ChristianSahlbergKristine KleiviSkjervenHelle KristineFritzmanBritt, Ulitsky I, Diederichs S, Wiemann S, Yakhini Z, Kristensen VN, Børresen-Dale AL, Yarden Y.

EMBO Mol Med. 2016 Sep 1;8(9):1052-64. doi: 10.15252/emmm.201606198. Print 2016 Sep.

11.

Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2.

Ho JY, Hsu RJ, Wu CH, Liao GS, Gao HW, Wang TH, Yu CP.

Oncotarget. 2016 Aug 16;7(33):53853-53868. doi: 10.18632/oncotarget.10793.

12.

FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance.

Bartel CA, Parameswaran N, Cipriano R, Jackson MW.

Oncotarget. 2016 Aug 9;7(32):52597-52612. doi: 10.18632/oncotarget.9544. Review.

13.

A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.

Chen X, Han J, Chu J, Zhang L, Zhang J, Chen C, Chen L, Wang Y, Wang H, Yi L, Elder JB, Wang QE, He X, Kaur B, Chiocca EA, Yu J.

Oncotarget. 2016 May 10;7(19):27764-77. doi: 10.18632/oncotarget.8526.

14.

The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair.

Bassi C, Li YT, Khu K, Mateo F, Baniasadi PS, Elia A, Mason J, Stambolic V, Pujana MA, Mak TW, Gorrini C.

Cell Death Differ. 2016 Jul;23(7):1198-208. doi: 10.1038/cdd.2015.173. Epub 2016 Feb 26.

15.

SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.

Matalkah F, Martin E, Zhao H, Agazie YM.

Breast Cancer Res. 2016 Jan 4;18(1):2. doi: 10.1186/s13058-015-0659-z.

16.

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

Carey LA, Berry DA, Cirrincione CT, Barry WT, Pitcher BN, Harris LN, Ollila DW, Krop IE, Henry NL, Weckstein DJ, Anders CK, Singh B, Hoadley KA, Iglesia M, Cheang MC, Perou CM, Winer EP, Hudis CA.

J Clin Oncol. 2016 Feb 20;34(6):542-9. doi: 10.1200/JCO.2015.62.1268. Epub 2015 Nov 2.

17.

ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer.

Liu Y, Baglia M, Zheng Y, Blot W, Bao PP, Cai H, Nechuta S, Zheng W, Cai Q, Shu XO.

Oncotarget. 2015 Dec 1;6(38):41360-9. doi: 10.18632/oncotarget.6023.

18.

Characterization of DNA variants in the human kinome in breast cancer.

Agarwal D, Qi Y, Jiang T, Liu X, Shi W, Wali VB, Turk B, Ross JS, Fraser Symmans W, Pusztai L, Hatzis C.

Sci Rep. 2015 Sep 30;5:14736. doi: 10.1038/srep14736.

19.

Cadmium promotes the proliferation of triple-negative breast cancer cells through EGFR-mediated cell cycle regulation.

Wei Z, Song X, Shaikh ZA.

Toxicol Appl Pharmacol. 2015 Nov 15;289(1):98-108. doi: 10.1016/j.taap.2015.09.006. Epub 2015 Sep 15.

20.

Clinical implications of molecular heterogeneity in triple negative breast cancer.

Lehmann BD, Pietenpol JA.

Breast. 2015 Nov;24 Suppl 2:S36-40. doi: 10.1016/j.breast.2015.07.009. Epub 2015 Aug 5. Review.

Supplemental Content

Support Center